BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6757025)

  • 1. A rapid means of separating A14-125I-insulin from heterogeneously labeled insulin molecules for biologic studies.
    Stentz FB; Wright RK; Kitabchi AE
    Diabetes; 1982 Dec; 31(12):1128-31. PubMed ID: 6757025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding affinity of monoiodinated insulin tracers isolated after reversed-phase high-performance liquid chromatography.
    Welinder BS; Linde S; Hansen B; Sonne O
    J Chromatogr; 1983 Dec; 281():167-77. PubMed ID: 6365938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
    Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
    J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of radioiodinated human insulin by high performance liquid chromatography for a sensitive radioimmunoassay.
    Hsu CH; Hong TH; Yin KW; Tang TK; Wang SC; Chen ST; Lee LS; Chang TH
    J Formos Med Assoc; 1992 Jan; 91(1):9-14. PubMed ID: 1352342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
    Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid, high-yield method of producing mono-[125I]A14 iodoinsulin.
    Lioubin MN; Meier MD; Ginsberg BH
    Prep Biochem; 1984; 14(4):303-11. PubMed ID: 6393119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid separation of A14-125I-insulin from heterogeneous iodination mixtures by high performance liquid chromatography (HPLC).
    Marchetti P; Benzi L; Cecchetti P; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(1):31-4. PubMed ID: 6384442
    [No Abstract]   [Full Text] [Related]  

  • 8. Separation, isolation and characterization of the four monoiodinated insulin tracers using reversed-phase high-performance liquid chromatography.
    Welinder BS; Linde S; Hansen B
    J Chromatogr; 1983 Aug; 265(2):301-9. PubMed ID: 6355130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination.
    Zórad S; Svábová E; Klimes I; Macho L
    Endocrinol Exp; 1985 Dec; 19(4):267-75. PubMed ID: 3910407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A14-125I-monoiodoinsulin purified by high performance liquid chromatography (HPLC): cellular receptor binding properties and long-term stability.
    Benzi L; Marchetti P; Cecchetti P; Pezzino V; Gullo D; Masoni A; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(4):277-81. PubMed ID: 6399077
    [No Abstract]   [Full Text] [Related]  

  • 11. Early detection of degraded A14-125I-insulin in human fibroblasts by the use of high performance liquid chromatography.
    Stentz FB; Harris HL; Kitabchi AE
    Diabetes; 1983 May; 32(5):474-7. PubMed ID: 6341131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
    Sato H; Tsuji A; Hirai K; Kang YS
    Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical properties of A14-125I-monoiodoinsulin purified by high performance liquid chromatography.
    Benzi L; Marchetti P; Cecchetti P; Caricato F; Masoni A; Navalesi R
    J Nucl Med Allied Sci; 1984; 28(2):81-4. PubMed ID: 6392492
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies.
    Diaz JL; Wilkin TJ
    Clin Chem; 1988 Feb; 34(2):356-9. PubMed ID: 2449302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-related material in microbes: similarities and differences from mammalian insulins.
    LeRoith D; Shiloach J; Heffron R; Rubinovitz C; Tanenbaum R; Roth J
    Can J Biochem Cell Biol; 1985 Aug; 63(8):839-49. PubMed ID: 3933801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [125I]diiodoinsulins. Binding affinities, biologic potencies, and properties of their decay products.
    Pérez Maceda B; Linde S; Sonne O; Gliemann J
    Diabetes; 1982 Jul; 31(7):634-40. PubMed ID: 7160541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of biological variant insulin molecules from different species by reversed-phase high-performance liquid chromatography (HPLC).
    Kalant D; Crawhall JC; Posner BI
    Biochem Med; 1985 Oct; 34(2):230-40. PubMed ID: 3910033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
    Ryan MP; Peavy DE; Frank BH; Duckworth WC
    Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-mediated endocytosis of A14-125I-insulin by the nonfiltering perfused rat kidney.
    Sato H; Yoshioka K; Terasaki T; Tsuji A
    Biochim Biophys Acta; 1991 Apr; 1073(3):442-50. PubMed ID: 2015267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of radioiodinated secretin for radioimmunoassay.
    Hsu CH; Yin KW; Hong TH; Tang TK; Lee LS; Chang TH; Liu JD; Chen PH
    Ann Nucl Med; 1991 Sep; 5(3):83-7. PubMed ID: 1764343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.